Jim Cramer endorsed Oracle, Abbott Labs, Palantir, GXO Logistics, and Sweetgreen on "Mad Money".

On "Mad Money," Jim Cramer provided quick insights on various stocks. He praised Oracle for its data center capabilities, preferred Abbott Labs over AbbVie, and recommended Palantir instead of Core Scientific. Cramer was cautious about Clover Health, despite its strengths, and advised holding GXO Logistics, calling it valuable. He also lauded Sweetgreen as a "terrific" investment. The CNBC Investing Club Charitable Trust owns Abbott Laboratories shares.

October 16, 2024
3 Articles